SCHEMBL1099489

SCHEMBL1099489

CCCCN(c1sc2ccccc2c1C)S(=O)(=O)c1ccc(-c2nnn[nH]2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 4/20 0.40
ALOX5 P09917 3/20 0.39
ESR1 P03372 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
ATM Q13315 1/20 0.38
NR1I2 O75469 1/20 0.36
PTGES O14684 2/20 0.36
CYP2C8 P10632 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C18 P33260 1/20 0.34
CYP2C19 P33261 1/20 0.34
GAA P10253 1/20 0.34
HTR1A P08908 1/20 0.34
DRD2 P14416 1/20 0.34
HTR2A P28223 1/20 0.34
HTR7 P34969 1/20 0.34
HTR6 P50406 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
PSEN1 P49768 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1098613 0.90 ALOX5 (0.38) TRPM8ALOX5ESR1MEN1KMT2A
SCHEMBL1099376 0.87 TRPM8 (0.44) TRPM8ESR1HTR1ADRD2HTR2A
SCHEMBL1097814 0.86 TRPM8 (0.40) TRPM8MEN1KMT2AHTR1ADRD2
SCHEMBL1100076 0.83 TRPM8 (0.41) TRPM8ALOX5ESR1NR1I2PTGES
SCHEMBL1100555 0.80 ALOX5 (0.39) TRPM8ALOX5ESR1MEN1KMT2A
SCHEMBL1099075 0.79 TRPM8 (0.69) TRPM8
SCHEMBL1099908 0.78 TRPM8 (0.33) TRPM8ESR1HTR1ADRD2HTR2A
SCHEMBL1099179 0.78 TRPM8 (0.38) TRPM8ALOX5ESR1MEN1KMT2A
SCHEMBL1099919 0.78 TRPM8 (0.61) TRPM8ALOX5ESR1PTGESGAA
SCHEMBL13963096 0.78 TRPM8 (0.40) TRPM8ESR1HTR1ADRD2HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9434711-B2 Sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA, N.V. (BE) 2016-09-06 US disclosed
US-20140315899-A1 SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2014-10-23 US disclosed
CN-101801949-B Sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA NV 2014-09-24 CN disclosed
US-8809327-B2 Sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA, NV (BE) 2014-08-19 US disclosed
EP-2183239-B1 SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2012-08-22 EP disclosed
US-20120190674-A1 SULFONAMIDES AS TRPM8 MODULATORS BRANUM SHAWN T (US) 2012-07-26 US disclosed
US-8153682-B2 Sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA, NV (BE) 2012-04-10 US disclosed
US-20090264474-A1 SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA, N.V. (BE) 2009-10-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120190674-A1 SULFONAMIDES AS TRPM8 MODULATORS TRPM8, TRPM5, TRPM2 TRPM8 1/4885ALOX5 2892/4885ESR1 1247/4885
US-20140315899-A1 SULFONAMIDES AS TRPM8 MODULATORS TRPM8, TRPM5, TRPM2 TRPM8 1/4885ALOX5 2892/4885ESR1 1247/4885
US-20090264474-A1 SULFONAMIDES AS TRPM8 MODULATORS TRPM8, TRPM5, TRPM2 TRPM8 1/4885ALOX5 2892/4885ESR1 1247/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.